0 0
Read Time:10 Second

The Exchange has sought clarification from Syngene International Limited with respect to recent news item captioned Syngene expands Biologics facility with new ADC bioconjugation capability. The response from the Company is awaited. |SUBJECT: News Verification

Happy
0 0 %
Sad
0 0 %
Excited
0 0 %
Sleepy
0 0 %
Angry
0 0 %
Surprise
0 0 %
Mb Buch

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *